Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A randomised 2x2 trial of community versus hospital rehabilitation, followed by telephone or conventional follow up; impact on quality of life, exercise capacity and use of health care resources
ISRCTN ISRCTN86821773
ClinicalTrials.gov identifier
Public title A randomised 2x2 trial of community versus hospital rehabilitation, followed by telephone or conventional follow up; impact on quality of life, exercise capacity and use of health care resources
Scientific title
Acronym N/A
Serial number at source HTA 01/15/10
Study hypothesis Pulmonary rehabilitation is a program of supervised exercises and education to improve the function and quality of life of patients with chronic obstructive pulmonary disease (COPD) (chronic lung disease, predominantly caused by smoking). To date, this treatment has usually been carried out in hospital, where research has already shown it to be effective. Programs typically last for 6 weeks, but improvements persist much longer. For maximum benefit patients must be assisted to change their lifestyles. It is possible that the importance attached to being treated in hospital is more likely to convince patients to change their lifestyles. Alternatively, those treated in a community setting may identify the treatment more with day to day life and hence be more likely to make ongoing changes. This study randomises patients to receive their rehabilitation program in either hospital or community setting to see if one is superior to the other. This will be evaluated over 18 months to see how the effect persists, with measures of purely physical function (exercise), quality of life and use of healthcare status being evaluated. In addition, half of the patients will receive telephone support to see if this can cost effectively enhance the persistence of treatment effect.

More details can be found at http://www.hta.ac.uk/1316

Please note that, as of 24 January 2008, the start and end date of this trial were updated from 1 July 2002 and 30 June 2006 to 1 November 2002 and 31 July 2007, respectively.

Please note that as of 04/05/10 this record was extensively updated. All updates can be found in the relevant field with the above update date.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised 2x2 factorial trial
Countries of recruitment United Kingdom
Disease/condition/study domain Chronic obstructive pulmonary disease
Participants - inclusion criteria Added 04/05/10:
1. Diagnosis of COPD as defined by British Thoracic Society guidelines
2. Medical Research Council (MRC) grade 3 dyspnoea or worse despite optimal care
3. Clinically stable 4 weeks prior to commencing programme
4. Written informed consent
Participants - exclusion criteria Added 04/05/10:
1. Lack of informed consent
2. Unwilling/lack of motivation to make lifestyle changes
3. Inability to hear and understand educational talks and exercise instructions (hearing aids and interpreters may be used if appropriate)
4. Prognosis under 2 years from any disease
5. Long term oxygen therapy or any requirement for oxygen therapy on exercise
6. Unstable or uncontrolled cardiac disease
7. Musculoskeletal problems precluding exercise training
Anticipated start date 01/11/2002
Anticipated end date 31/07/2007
Status of trial Completed
Patient information material
Target number of participants Added 04/05/10: 240
Interventions Participants were randomised to one of four groups:
1. Hospital rehabilitation with no telephone follow-up
2. Hospital rehabilitation with telephone follow-up
3. Community rehabilitation with no telephone follow-up
4. Community rehabilitation with telephone follow-up
Primary outcome measure(s) Added 04/05/10:
Shuttle walking test (ESWT), assessed post-rehabilitation and at 18 months
Secondary outcome measure(s) Added 04/05/10:
Health-related quality of life, assessed by Chronic Respiratory Questionnaire (CRQ), Short form-36 (SF-36) and EuroQol (EQ-5D)
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20146902
Contact name Dr  Roderick Allan  Lawson
  Address Dept of Respiratory Medicine
Royal Hallamshire Hospital
Glossop Road
  City/town Sheffield
  Zip/Postcode S10 2JF
  Country United Kingdom
  Tel +44 0 114 271 2958
  Fax +44 0 114 271 1836
  Email rod.lawson@sth.nhs.uk
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Tel +44 (0)1132 545 843
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 25/04/2003
Last edited 04/05/2010
Date ISRCTN assigned 25/04/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central